lemaitre.comCrawled Nov 11, 2026
LeMaitre will be exhibiting at MAC.
To register, please contact Kscheunemann@lemaitre.com.
Dr. John Lucas will be discussing his surgical technique and outcomes from over 2,000 successful arteriovenous fistulas, Training Schedule: Monday - Arrivals Airport-Memphis TN (MEM) or Jackson, MS (JAN) Dinner Presentation - 7pm Giardina's Tuesday - Case Observation 7am-3pm (6-8 creations/revisions) Departure - 3pm
JJ Pellegrino, Chief Financial Officer, will present at Needham Growth Conference on Wednesday, January 16, 2019, at the Lotte New York Palace Hotel in New York, NY. The Company is scheduled to present at 2:50 p.m. EST.
JJ Pellegrino, Chief Financial Officer, will present at Needham Growth Conference on Wednesday, January 15, 2020, at the Lotte New York Palace Hotel in New York, NY. The Company is scheduled to present at 10:40 a.m. EST.
LeMaitre develops vascular surgery tools through research and innovation.
LeMaitre Vascular, Inc. reports Q3 2026 financial results and announces a quarterly dividend of **$0.25 per share**. The company, specializing in vascular devices, implants, and services, also provides updated guidance for investors. The dividend reflects continued profitability in its core medical technology segment.
Nov 2026LeMaitreNews article
LeMaitre Vascular announces Q2 2026 financial results, including a $0.25 per share quarterly dividend. The company, specializing in vascular devices and implants, also provides updated guidance for investors. Revenue and operational performance details are included in the earnings report.
Aug 2026LeMaitreNews article
LeMaitre Vascular announces Q1 2026 financial results, including a $0.25 per share quarterly dividend. The company, specializing in vascular devices and implants, also provides updated guidance for investors. The announcement follows the release of first-quarter earnings data.
May 2026LeMaitreNews article
LeMaitre Vascular announces Q4 2025 financial results, including a 25% dividend increase to $0.25 per share. The company, specializing in vascular devices and implants, also provides updated guidance for investors. The results reflect performance in its core medical technology segments.
Feb 2026LeMaitreNews article
